ENANTIOS AG
- Biotech – industrial & Environmental
- Medical device or technology
- Other R&D services
- Synthesis, analytic, diagnostic services
- CMO, CRO
Instrumentation and services for the characterization of complex and chiral molecules.
In more detail, at Enantios (www.enantios.com), we develop platforms tailored for simple and fast structural analysis of complex biologics. Our technology is particularly well-suited to support characterization efforts around LDDs, especially when it comes to:
- Chirality confirmation and conformational analysis of degrader molecules and their target-bound complexes
- Non-destructive, in-vial testing for rapid screening and batch-to-batch consistency
- Insights into folding integrity and payload impact on protein structure—useful in early development and QC stages
We’ve successfully applied our platform to antibody-drug conjugates (ADCs) and we are looking forward to apply our technology to your applications.
Enantios` CEO, Dr. Carin Lightner, will be at the BIO International convention so please reach out and arrange a meeting!
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}